access to medicines

Ghana-based pharmaceutical supply chain startup mPharma has locked up $35 million in Series D funding, TechCrunch reported last week.

A portion of the funds will fuel the expansion of mPharma’s Mutti pharmacies in eight African markets, per the article, which said the pharmacies will offer a first point of care for patients, with services including medical consultations and diagnostics.

The new investments bring mPharma’s total haul across multiple financing rounds to $65…

Médecins Sans Frontières (MSF) and Human Rights Watch (HRW) are lobbying the U.S. government to force Pfizer and Moderna to share their Covid-19 mRNA technology with developing country vaccine manufacturers, the organizations said last week.

In an open letter, the activist groups quoted a December report by researchers from MSF and AccessIBSA that identified 100 manufacturers across Africa, Asia and Latin America with the “technical requirements and quality standards to manufacture…

The Access to Medicine (AtM) Foundation announced Tuesday that it will expand its biannual ranking of the 20 largest pharmas to include monitoring of the world’s most important generic, vaccine, diagnostics, and medical gas companies.

Citing an “unacceptable gap between the ‘haves’ and the ‘have-nots,’” an AtM press release said the Covid-19 pandemic had revealed “acute issues of access,” not only to medicines and vaccines but to medical oxygen and other essential health products.…

Boston University has published the last of its annual reports evaluating the progress of Access Accelerated, the industry-led initiative to address noncommunicable disease burdens in LMICs.

The 2021 Access Observatory identified 61 active access programs, with a majority focused on cancer. That number represents a decline from 75 active programs in 2019 and 73 in 2018. The report cited the “unprecedented” challenge of Covid-19 as impeding companies’ ability to initiate new NCD…

Public agencies in over 100 LMICs will be able to buy SD Biosensor’s STANDARD Q HIV/Syphilis Combo test for less than $1 through a collaboration between the company, the Clinton Health Access Initiative (CHAI) and Britain’s MedAccess, the partners announced Monday.

A volume guarantee agreement between MedAccess and the South Korean manufacturer will make the WHO-prequalified diagnostic available to a cohort of countries bearing 98% of the global burden of congenital syphilis and 93% of…

Teva announced Wednesday a $4 billion “sustainability-linked financing framework” that the company will use to refinance its debt while incentivizing its efforts to increase access to medicines in LMICs by 150%.

The Access to Medicine Foundation has independently validated the Tel Aviv-based company’s framework, which also includes a goal to reduce Scope 1 and 2 greenhouse gas emissions by 25% by 2025, the press release said.

Novartis and Sanofi have also issued bonds with rates…

WHO published results last week from its biennial Expert Committee on the Selection and Use of Essential Medicines meeting, adding 20 new treatments to its Model List of Essential Medicines (EML) and 17 to its children’s list (EMLc).

The additions include “new treatments for various cancers, insulin analogues and new oral medicines for diabetes, new medicines to assist people who want to stop smoking, and new antimicrobials to treat serious bacterial and fungal infections,” according…

In a three-way financing agreement announced Wednesday, Gavi will fund GSK’s continued manufacturing of the antigen for the British pharma company’s RTS,S/AS01e malaria vaccine, pending a WHO decision expected later this year on whether to recommend the shot for broader use.

If WHO does endorse and Gavi’s board approves a malaria vaccination program, GSK would then credit the value of the Gavi-funded costs toward procurement of finished doses, according to a joint press release.…

The Geneva-based Global Antibiotic Research and Development Partnership (GARDP) announced Tuesday that it has signed a memorandum of understanding (MOU) with the Clinton Health Access Initiative (CHAI) and Shionogi to accelerate LMIC access to the Osaka-based drugmaker’s antibiotic cefiderocol (Fetroja).

The collaboration will help introduce the drug—indicated for bacterial infections in patients with limited treatment options—into health systems and provide clinical guidance to…

WHO announced Monday that the COVAX partnership’s first Covid-19 mRNA vaccine technology transfer hub will launch with a South African consortium comprising Biovac, Afrigen Biologics and Vaccines, a “network of universities,” and the Africa Centres for Disease Control and Prevention.

A press release quoted WHO Director-General Tedros Adhanom Ghebreyesus as saying Covid-19 had “highlighted the importance of local production to address health emergencies,” while South Africa’s…